Two new antivirals for HIV may be approved soon

Two new antivirals for HIV may be approved soon...Viracept (nelfinavir) and Rescriptor (delavirdine).

Viracept will be the fourth protease inhibitor on the market.

It has just been released through an expanded access program...for patients with advanced AIDS when the other protease inhibitors don't work or cause intolerable side effects.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote